Stock ENA ENABLENCE TECHNOLOGIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Enablence Technologies Inc.

Equities

ENA

CA2924833023

Medical Equipment, Supplies & Distribution

Market Closed - Toronto S.E.
Other stock markets
 10:26:46 2024-04-26 am EDT 		5-day change 1st Jan Change
0.7 CAD 0.00% Intraday chart for Enablence Technologies Inc. 0.00% -51.72%
Feb. 29 Enablence Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
2023 Enablence Technologies Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023 CI

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 18.7 9.802 7.172 7.172 25.94 23.55
Enterprise Value (EV) 1 32.03 30.89 35.18 42.22 31.73 31.91
P/E ratio -1.8 x -1 x -0.75 x -1.12 x 1.6 x -2.74 x
Yield - - - - - -
Capitalization / Revenue 5.52 x 6.88 x 6.51 x 2.84 x 13.1 x 12 x
EV / Revenue 9.45 x 21.7 x 32 x 16.7 x 16 x 16.3 x
EV / EBITDA -4.11 x -4.06 x -5.58 x -10.2 x -5.62 x -4.17 x
EV / FCF -5.4 x -6.27 x -7.1 x -11.3 x -7.62 x -7.41 x
FCF Yield -18.5% -16% -14.1% -8.82% -13.1% -13.5%
Price to Book -1.32 x -0.42 x -0.23 x -0.18 x -2.65 x -1.82 x
Nbr of stocks (in thousands) 5,183 5,349 5,349 5,349 18,590 18,590
Reference price 2 3.608 1.832 1.341 1.341 1.395 1.267
Announcement Date 10/29/18 10/28/19 5/12/21 10/21/21 10/28/22 11/1/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 3.388 1.424 1.101 2.521 1.978 1.961
EBITDA 1 -7.786 -7.613 -6.31 -4.145 -5.644 -7.644
EBIT 1 -8.512 -7.92 -6.462 -4.296 -5.784 -7.842
Operating Margin -251.24% -556.18% -586.92% -170.41% -292.42% -399.9%
Earnings before Tax (EBT) 1 -10.38 -9.78 -9.557 -5.041 11.49 -9.59
Net income 1 -10.38 -9.78 -9.557 -5.041 11.69 -8.605
Net margin -306.29% -686.8% -868.03% -199.96% 591.15% -438.81%
EPS 2 -2.002 -1.833 -1.787 -1.200 0.8700 -0.4629
Free Cash Flow 1 -5.93 -4.928 -4.954 -3.726 -4.162 -4.305
FCF margin -175.03% -346.09% -449.99% -147.78% -210.41% -219.51%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 10/29/18 10/28/19 5/12/21 10/21/21 10/28/22 11/1/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 13.3 21.1 28 35 5.79 8.36
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -1.713 x -2.77 x -4.439 x -8.455 x -1.026 x -1.093 x
Free Cash Flow 1 -5.93 -4.93 -4.95 -3.73 -4.16 -4.3
ROE (net income / shareholders' equity) 112% 52.1% 34.2% 14.1% -47.2% 75.8%
ROA (Net income/ Total Assets) -77.3% -157% -223% -179% -256% -132%
Assets 1 13.43 6.239 4.283 2.822 -4.569 6.5
Book Value Per Share 2 -2.730 -4.370 -5.960 -7.430 -0.5300 -0.6900
Cash Flow per Share 2 0.0200 0.0100 0.0300 0.0400 0.0100 0.2300
Capex 1 0.39 0.18 0.19 0.06 0.11 0.52
Capex / Sales 11.36% 12.85% 17.08% 2.54% 5.61% 26.26%
Announcement Date 10/29/18 10/28/19 5/12/21 10/21/21 10/28/22 11/1/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ENABLENCE TECHNOLOGIES INC. Stock Enablence Technologies Inc.
-51.72% 9.62M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. ENA Stock
  4. Financials Enablence Technologies Inc.